An innovative method for the detection of contaminant viral genome in cell cultures by DI BELLA, S. et al.
AN INNOVATIVE METHOD FOR THE DETECTION OF CONTAMINANT VIRAL GENOME
IN CELL CULTURES
Di Bella S., Di Marco P., Russotto L., Cannella V., Altomare R., Purpari G., Guercio A.
Istituto Zooprofilattico Sperimentale della Sicilia, Area Diagnostica Virologica, Palermo
INTRODUCTION
The use of cell cultures involves different fields of biology, from diagnosis to research. Moreover, technologies based on animal cells represent 
a useful tool to the development of biological products for the prophylaxis and therapy in humans and animals. Therefore, it is necessary to 
perform quality controls, including virological tests. Several tests performed in research laboratories are able to discriminate one or more viral 
species, but it is not possible to demonstrate the presence of contaminant viral genome with one non-specific method. The aim of this work 
consisted on the realization of a biomolecular method able to detect and to identify by sequencing extraneous viral genome in cell cultures of 
animal and human origin in the absence of any specific information about the virus.
RESULTS
The detection of the amplification products by electrophoresis showed that the optimal
concentrations of nucleases used during viral capsid extraction were 50U of RNase and 
150U of DNase.
The confirmation that the viral capsids extraction protocol was developed successfully and 
that the method did not affect the viability of the viruses was obtained by inoculating the 
samples on new sensitive cell monolayers. All samples shown cytopathogenic effect
demonstrating that the vitality of the virus used was not compromised by the steps of 
extraction.
DOP-PCR generated a smear of DNA fragments (200-1600 bp) visible on agarose gel 
(Figure 1). The bands present in lanes related to infected samples were compared with 
those present in lanes of samples used as negative control. The bands present in the lanes of 
the infected samples and absent in those of control samples were considered to identificate
the extraneous genome. These bands were the most evident. The other bands represented
the amplification product of cell genome residues. Specific PCR for the viruses used, 
cloning and sequencing confirmed the identity of the viral genome in the bands selected. 
METHODS
Positivization of test samples. Cell substrates were experimentally infected with 
known viruses (Table 1). Uninfected cells were used as negative controls. 
Viral capsid extraction procedure to separate the viral genome from the cell
genome (1). The separation was performed by RNase and DNase and by 
centrifugation, exploiting the different density of capsids. Several concentrations 
of nucleases (50U, 100U, 150U, 200U) were tested to determinate the appropriate 
one which is able to digest the cellular genome, leaving the viral capsids intact.
RNA and DNA extraction. RNA and DNA were extracted by High Pure                         
RNA Isolation Kit (Roche) and DNeasy Blood & Tissue Kit (Qiagen) according 
to manufacturer protocols.
RNA retrotransciption. Retrotrascription was performed by SuperScript VILO 
cDNA Synthesis Kit (Invitrogen).
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CONCLUSIONS
The sequence-independent amplification and subsequent sequencing of nucleic acids has 
shown to be a method capable to identify viruses of different nature, DNA or RNA viruses 
with or without envelope. 
Therefore, it is conceivable the application of this method to the quality controls of cell 
lines used in diagnostics and research by optimizing and validating the procedures and 
expanding experimentation to retroviruses and circovirus. Moreover, this method may be 
particularly useful to ensure the virologic biosafety of mesenchymal stem cells that are 
used for in vivo implantation and cryopreserved.
Cell Culture Virus Virus Characteristics
MDCK 
(Madin Darby Canine Kidney) Canine Herpes Virus 
DNA virus
with envelope
MDCK 
(Madin Darby Canine Kidney) Canine Adenovirus 
DNA virus
without envelope
FRhK-4 
(Fetal Rhesus monkey Kidney) Hepatitis A Virus (HAV)
RNA virus
with envelope
VERO ORWELL
(Orwell African green monkey 
kidney)
Canine Distemper Virus RNA virus
without envelope
Table 1. Cells and viruses used for experimental infection.
Figure 1. Lanes 1 and 2 are related to the genome amplified
from pellet and supernatant samples experimentally infected
with the virus. Lanes 3 and 4 are related to pellet and 
supernatant samples of control. The bands related to the virus 
are those in the red boxes.
Degenerate Oligonucleotide Primed PCR. DOP-PCR was set up to amplify the viral genome in a single reaction using a single degenerated 
primer (5’-CCGACTCGAGNNNNNNATGTGG-3’). DOP-PCR is divided in two phases with different cycles: 
 phase 1 (low stringency) - 5 cycles at low annealing temperature.
 phase 2 (high stringency) - 35 cycles at high annealing temperature that increases the specificity of primer during amplification of the 
sequence. Amplification products were resolved on agarose gel, excised from the gel and recovered using a gel extraction kit (2, 3).
Cloning and sequencing. Amplification products were ligated to the pJET/blunt cloning vector. The ligated products were then transformed 
into XL1-Blue Competent Cells. DNA extracted from bacterial clones containing DOP-PCR-amplified products was sequenced. Sequences 
were compared with those submitted previously to Gene Bank.
